Viral Escape from Neutralizing Antibodies in Early Subtype A HIV-1 Infection Drives an Increase in Autologous Neutralization Breadth - Test2 - elhamkhani - TriplyDB

Viral Escape from Neutralizing Antibodies in Early Subtype A HIV-1 Infection Drives an Increase in Autologous Neutralization Breadth

Viral Escape from Neutralizing Antibodies in Early Subtype A HIV-1 Infection Drives an Increase in Autologous Neutralization Breadth

http://www.wikidata.org/entity/Q27676728

about

Development of broadly neutralizing antibodies from autologous neutralizing antibody responses in HIV infection Virological features associated with the development of broadly neutralizing antibodies to HIV-1 Vaccine-Elicited Tier 2 HIV-1 Neutralizing Antibodies Bind to Quaternary Epitopes Involving Glycan-Deficient Patches Proximal to the CD4 Binding Site Deconstructing the Antiviral Neutralizing-Antibody Response: Implications for Vaccine Development and Immunity An efficiently cleaved HIV-1 clade C Env selectively binds to neutralizing antibodies Short-Sighted Virus Evolution and a Germline Hypothesis for Chronic Viral Infections.Dynamic electrophoretic fingerprinting of the HIV-1 envelope glycoprotein.Broadly Neutralizing Antibodies as Treatment: Effects on Virus and Immune System A mechanistic understanding of allosteric immune escape pathways in the HIV-1 envelope glycoprotein.Transmitted virus fitness and host T cell responses collectively define divergent infection outcomes in two HIV-1 recipients.Viral escape from HIV-1 neutralizing antibodies drives increased plasma neutralization breadth through sequential recognition of multiple epitopes and immunotypes The type-specific neutralizing antibody response elicited by a dengue vaccine candidate is focused on two amino acids of the envelope protein.HIV-1 non-macrophage-tropic R5 envelope glycoproteins are not more tropic for entry into primary CD4+ T-cells than envelopes highly adapted for macrophages.Strategies to guide the antibody affinity maturation process Characterization and Implementation of a Diverse Simian Immunodeficiency Virus SIVsm Envelope Panel in the Assessment of Neutralizing Antibody Breadth Elicited in Rhesus Macaques by Multimodal Vaccines Expressing the SIVmac239 Envelope.Breakthrough of SIV strain smE660 challenge in SIV strain mac239-vaccinated rhesus macaques despite potent autologous neutralizing antibody responses.Decreased T Follicular Regulatory Cell/T Follicular Helper Cell (TFH) in Simian Immunodeficiency Virus-Infected Rhesus Macaques May Contribute to Accumulation of TFH in Chronic Infection.Effect of Glycosylation on an Immunodominant Region in the V1V2 Variable Domain of the HIV-1 Envelope gp120 Protein.Saturation Mutagenesis of the HIV-1 Envelope CD4 Binding Loop Reveals Residues Controlling Distinct Trimer Conformations.Diversification in the HIV-1 Envelope Hyper-variable Domains V2, V4, and V5 and Higher Probability of Transmitted/Founder Envelope Glycosylation Favor the Development of Heterologous Neutralization Breadth Effects of partially dismantling the CD4 binding site glycan fence of HIV-1 Envelope glycoprotein trimers on neutralizing antibody induction.Mechanisms of escape from the PGT128 family of anti-HIV broadly neutralizing antibodies A pathway to HIV-1 neutralization breadth.Multiplexed highly-accurate DNA sequencing of closely-related HIV-1 variants using continuous long reads from single molecule, real-time sequencing.HIV-1 escapes from N332-directed antibody neutralization in an elite neutralizer by envelope glycoprotein elongation and introduction of unusual disulfide bonds.HIV vaccines: a brief overview.Immune System Regulation in the Induction of Broadly Neutralizing HIV-1 Antibodies.Cooperation between Strain-Specific and Broadly Neutralizing Responses Limited Viral Escape and Prolonged the Exposure of the Broadly Neutralizing Epitope.Gp120 V5 Is Targeted by the First Wave of Sequential Neutralizing Antibodies in SHIVSF162P3N-Infected Rhesus Macaques.

P2860

Q27022652-699E0968-EAA8-430A-86D9-3D0FEEE0AF4B Q27025177-801CC550-AF21-4843-BB2A-A9080A4FAF69 Q27319450-23DD4471-33DE-41C6-8204-BDCEF7F5DAB5 Q27654848-BE33DA11-2278-4360-9FF7-E008B5307043 Q28545185-12E3CAAD-1CAE-454A-9B83-B3945ABB0608 Q30234948-1F3F6E7F-580C-4CB3-8FB7-242E967C33BB Q30454762-38DD404D-6ECC-40F3-8079-090409B847E3 Q33592852-4292E334-64AD-45B3-8948-166A6AD7551E Q34733504-6E56934C-D19A-4D86-AEBE-43F6C6C56F2F Q34874985-61594C59-7354-4374-AAB7-821A40395B1E Q35034268-6AF92F0F-3FA0-4C0E-A3FF-D0F4B566EE3E Q35069160-54DAD23F-77C0-4FE4-9BD4-CC1727BC9EBD Q35216488-20932CDB-34C6-4A63-B3EB-5F1845E93DDD Q35685300-6F25BF1D-D073-4E53-9960-8B061A73670B Q35914362-EAD95EA0-0D06-478A-A31D-5ECED4E8CE2F Q36008380-F993DDE5-B5A2-40EF-952C-3EA5C0E5FC76 Q36075199-C21F3117-E3C6-459E-BCE2-548405E9F5AF Q36157560-F52CFE1B-EF51-44B4-B156-94790D586E70 Q36184440-DC716D73-23DE-4AAB-86E5-6E0AA619F852 Q36194234-79F64B09-0601-4771-AD7D-86C079D62D9B Q36303368-98F632A0-6CFE-46CA-ADDA-79848BB5C0BE Q36531018-2E055699-A6D5-4C35-9A1E-232EF7EC757E Q36625139-D09FD2AE-73FB-4E6C-B9DF-A9EF92302F24 Q36676496-A0186EED-5190-42FF-BCF7-D46874C25212 Q37073506-685FCBCA-A314-4FCA-A42A-440497F9CF91 Q38210557-B8BDE754-C67F-4D6F-81E7-7AF8F2CB6839 Q38220506-84E9C686-E008-4ED1-A31C-122CB1EA9AC1 Q40134111-8ECD21BC-3938-4554-9DBF-4537110F6E3E Q55373995-AE86A24B-8D56-4CD2-B94C-2E6345F5F331

P2860

Viral Escape from Neutralizing Antibodies in Early Subtype A HIV-1 Infection Drives an Increase in Autologous Neutralization Breadth

http://www.wikidata.org/entity/Q27676728

description

2013 nî lūn-bûn

@nan

2013 թուականի Փետրուարին հրատարակուած գիտական յօդուած

@hyw

2013 թվականի փետրվարին հրատարակված գիտական հոդված

@hy

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

name

Viral Escape from Neutralizing ...... ologous Neutralization Breadth

@ast

Viral Escape from Neutralizing ...... ologous Neutralization Breadth

@en

Viral Escape from Neutralizing ...... ologous Neutralization Breadth

@nl

type

label

Viral Escape from Neutralizing ...... ologous Neutralization Breadth

@ast

Viral Escape from Neutralizing ...... ologous Neutralization Breadth

@en

Viral Escape from Neutralizing ...... ologous Neutralization Breadth

@nl

prefLabel

Viral Escape from Neutralizing ...... ologous Neutralization Breadth

@ast

Viral Escape from Neutralizing ...... ologous Neutralization Breadth

@en

Viral Escape from Neutralizing ...... ologous Neutralization Breadth

@nl

P1433

Q27676728-A3B65DB8-2D37-466D-939B-949F53CFE90E

P1476

Q27676728-3E17256B-3772-4631-8135-2955413F244F

P2093

Q27676728-2E0A8AC7-783A-421C-BF4C-7E8018F49195

Q27676728-337234A6-1EEA-41C8-BE8B-4A2ACB61B959

Q27676728-7007B58D-6D9A-4F59-8903-AE86313E5532

Q27676728-736F47E4-60F4-4F76-B7FD-D219C9B290F1

Q27676728-A6C42764-3B31-4596-9A20-BCA2F11C2808

Q27676728-AA4159A7-AAFD-4B48-877F-2C4554957FEB

Q27676728-BB7F8FB9-B37D-4142-8EFF-1B750A6372FB

Q27676728-CA396D50-C26C-4B96-ACD6-E2D3E25FBCBB

Q27676728-DD849DE2-8354-4207-A37E-6B41FDD6470C

Q27676728-E3E665B6-6C83-4E3A-866D-E910DEE6F61A

P2860

Q27676728-0706CD22-078E-4414-A58C-55F4AB6F731A

Q27676728-07E07282-D265-4461-9394-C47CF83332D1

Q27676728-10AF09B8-1515-4AE9-A40D-1013B4A9D485

Q27676728-1172EFEA-5991-46DC-9D20-89CE903840E1

Q27676728-14B1B8A2-4F3F-404D-AFA2-4F6D776B0B55

Q27676728-1AF2915A-DFE9-4CEE-8E6E-A1DFC57B803C

Q27676728-1D1C6B91-7BD5-4700-927C-4FEBAE9CEDBD

Q27676728-1E290EE4-9E8E-4C03-8A4D-BD0757360011

Q27676728-1F384A3C-922F-4A37-80F1-4D7C0030C597

Q27676728-2033DDD1-71F7-49E2-9081-C65805BA2F80

P304

Q27676728-878C4366-3A26-464A-8FD6-2D06E3E08E8C

P31

Q27676728-39DE7737-DECA-4BB7-8319-1D2C3AB6DA72

P3181

Q27676728-E6097896-7306-4275-833F-B9DEDAEAB2C3

P356

Q27676728-DC800D84-9D42-4456-BBD7-F8BF5159F824

P433

Q27676728-781C7688-8D8D-4B71-86D0-6111B78BABD6

P478

Q27676728-950F19E8-1F82-4485-9524-DBFFB8A54410

P50

Q27676728-3807D3E5-D7A5-4D19-B131-AECACC211228

Q27676728-55925AA7-A34A-43C1-B565-F32DCDB3B5CB

Q27676728-79F92FA2-D0C9-4288-BCCD-29E656107B57

Q27676728-A443B1C4-F94F-4342-B4E5-5F353F7A0271

P577

Q27676728-B68BACAD-B38D-46B3-A377-30793930FFA5

P5875

Q27676728-3635FD78-E9A0-4DCC-8825-604208A8ED08

P698

Q27676728-EDC96515-3DA3-435F-9AB8-820DC5B203B5

P921

Q27676728-6FBCAE0B-B995-4764-9D11-A5FDE4B3C86C

P932

Q27676728-F4E0AC77-7814-4B3D-852B-900EC2297A4F

P3181

P356

JOURNAL.PPAT.1003173

P1433

P1476

Viral escape from neutralizing ...... ologous neutralization breadth

@en

P2093

Anurag Sethi

http://www.w3.org/2001/XMLSchema#string

Cynthia A Derdeyn

http://www.w3.org/2001/XMLSchema#string

Emmanuel Cormier

http://www.w3.org/2001/XMLSchema#string

Eric Hunter

http://www.w3.org/2001/XMLSchema#string

Etienne Karita

http://www.w3.org/2001/XMLSchema#string

James E Robinson

http://www.w3.org/2001/XMLSchema#string

Jianhui Tian

http://www.w3.org/2001/XMLSchema#string

Katja Pfafferot

http://www.w3.org/2001/XMLSchema#string

Ling Yue

http://www.w3.org/2001/XMLSchema#string

Megan K Murphy

http://www.w3.org/2001/XMLSchema#string

P2860

Increasing the potency and breadth of an HIV antibody by using structure-based rational design

Structural definition of a conserved neutralization epitope on HIV-1 gp120

Processing of X-ray diffraction data collected in oscillation mode

Structures of HIV-1 gp120 envelope glycoproteins from laboratory-adapted and primary isolates

Structural basis of tyrosine sulfation and VH-gene usage in antibodies that recognize the HIV type 1 coreceptor-binding site on gp120

Structure of HIV-1 gp120 V1/V2 domain with broadly neutralizing antibody PG9

Molecular architecture of native HIV-1 gp120 trimers

Structural Basis of the Cross-Reactivity of Genetically Related Human Anti-HIV-1 mAbs: Implications for Design of V3-Based Immunogens

Structure of HIV-1 gp120 with gp41-interactive region reveals layered envelope architecture and basis of conformational mobility

Structural Basis for Broad and Potent Neutralization of HIV-1 by Antibody VRC01

P304

e1003173

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

190598

http://www.w3.org/2001/XMLSchema#string

P356

10.1371/JOURNAL.PPAT.1003173

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

9

http://www.w3.org/2001/XMLSchema#string

P50

Persephone Borrow

Xiang-Peng Kong

P577

2013-02-28T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

235882682

http://www.w3.org/2001/XMLSchema#string

P698

23468623

http://www.w3.org/2001/XMLSchema#string

P921

P932

3585129

http://www.w3.org/2001/XMLSchema#string